Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Md, USA.
J Thorac Cardiovasc Surg. 2013 Sep;146(3):638-46. doi: 10.1016/j.jtcvs.2012.07.070. Epub 2012 Aug 20.
OBJECTIVE: We evaluated the combined effect of hospital and surgeon volume on operative outcomes of mitral valve surgery in the United States. METHODS: The Nationwide Inpatient Sample was used to identify adult patients undergoing isolated mitral valve surgery for mitral regurgitation from 2003 to 2008. Hospitals and surgeons were separately stratified into equal-size tertiles according to annual overall mitral valve operative volumes. Multivariate logistic regression analysis was conducted, adjusting for multiple patient, hospital, and operative data, to determine the separate and combined effects of hospital and surgeon volume on operative outcomes. RESULTS: A total of 50,152 eligible patients were identified during the study period. Although both hospital and surgeon volume correlated significantly with operative mortality in separate risk-adjusted analyses, only lower surgeon volume persisted as a significant risk factor in the combined risk-adjusted analysis. Moreover, although hospital volume only accounted for 10.7% of the surgeon volume effect on increased mortality for low-volume surgeons, surgeon volume accounted for 74.5% of the hospital volume effect on increased mortality in low-volume hospitals. Surgeon, but not hospital, volume correlated with inpatient costs. Also, significant trends were seen with repair rates, with increasing surgeon volume demonstrating a relatively stronger correlation with the odds of repair (P < .001) than hospital volume (P = .01). CONCLUSIONS: The effect of hospital volume on operative outcomes of mitral valve surgery was largely driven by the individual surgeon volumes within that hospital. Conversely, surgeon volume affected these outcomes independently of hospital volume. Identifying the processes by which higher volume surgeons attain better outcomes in mitral valve surgery would therefore be prudent.
目的:我们评估了医院和外科医生手术量对美国二尖瓣手术手术结果的综合影响。
方法:利用全国住院患者样本,从 2003 年至 2008 年,识别出因二尖瓣反流而行单纯二尖瓣手术的成年患者。根据每年整体二尖瓣手术量,将医院和外科医生分别按相等大小的三分位数分层。进行多变量逻辑回归分析,调整了多个患者、医院和手术数据,以确定医院和外科医生手术量对手术结果的单独和综合影响。
结果:在研究期间,共确定了 50152 名符合条件的患者。尽管在单独的风险调整分析中,医院和外科医生的手术量都与手术死亡率显著相关,但只有较低的外科医生手术量在联合风险调整分析中仍然是一个显著的危险因素。此外,尽管医院量仅占低容量外科医生手术死亡率增加的外科医生量效应的 10.7%,但外科医生量占低容量医院手术死亡率增加的医院量效应的 74.5%。外科医生的手术量,而不是医院的手术量,与住院费用相关。此外,修复率也呈现出显著的趋势,随着外科医生手术量的增加,修复的几率与外科医生手术量呈正相关(P<0.001),而与医院手术量呈正相关(P=0.01)。
结论:医院手术量对二尖瓣手术手术结果的影响主要是由该医院内的个别外科医生手术量驱动的。相反,外科医生手术量独立于医院手术量影响这些结果。因此,明智的做法是确定高容量外科医生在二尖瓣手术中获得更好结果的过程。
J Thorac Cardiovasc Surg. 2012-8-20
J Thorac Cardiovasc Surg. 2012-4
J Heart Valve Dis. 2012-1
Interact Cardiovasc Thorac Surg. 2010-4
J Thorac Cardiovasc Surg. 2012-2-4
JAMA Netw Open. 2024-4-1
Struct Heart. 2022-11-3